Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
47,139,902
-
Share change
-
-3,110,982
-
Total reported value
-
$773,715,370
-
Put/Call ratio
-
82%
-
Price per share
-
$16.41
-
Number of holders
-
148
-
Value change
-
-$64,868,300
-
Number of buys
-
74
-
Number of sells
-
58
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q1 2021
As of 31 Mar 2021,
OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,139,902 shares.
The largest 10 holders included
Opaleye Management Inc., BlackRock Inc., SUMMER ROAD LLC, VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, STATE STREET CORP, EMERALD MUTUAL FUND ADVISERS TRUST, EMERALD ADVISERS, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
149
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.